Risk factor
Considerable default risk
Profitability factor
Slightly undervalued vs peers
About
Ion Beam Applications SA develops, manufactures, and supports medical devices and software solutions for cancer treatments in Belgium, the United States, and internationally. The company operates through Proton Therapy and Other Accelerators, and Dosimetry segments. The Proton Therapy and Other Accelerators segment develops, fabricates, and services medical and industrial particle accelerators, and proton therapy systems....
Company Valuation
Based on key historical and expected multiples, the stock is slightly undervalued relative to its peers. In particular, the stock is reasonably priced on P/E, of fair val
Target Price
The average target price of IBAB.BR is 16 and suggests 5% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommendation
Buy
Sell